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Purpose: To determine if computed tomographic (CT) texture fea-




Institutional review board waiver was obtained for this ret-
rospective analysis. Texture features of the entire primary 
tumor were assessed with contrast material–enhanced 
staging CT studies obtained in 57 patients as part of an 
ethically approved study and by using proprietary software. 
Entropy, uniformity, kurtosis, skewness, and standard devi-
ation of the pixel distribution histogram were derived from 
CT images without filtration and with filter values corre-
sponding to fine (1.0), medium (1.5, 2.0), and coarse (2.5) 
textures. Patients were followed up until death and were 
censored at 5 years if they were still alive. Kaplan-Meier 
analysis was performed to determine the relationship, if 
any, between CT texture and 5-year overall survival rate. 
The Cox proportional hazards model was used to assess 
independence of texture parameters from stage.
Results: Follow-up data were available for 55 of 57 patients. There 
were eight stage I, 19 stage II, 17 stage III, and 11 stage IV 
cancers. Fine-texture feature Kaplan-Meier survival plots for 
entropy, uniformity, kurtosis, skewness, and standard devi-
ation of the pixel distribution histogram were significantly 
different for tumors above and below each respective thresh-
old receiver operating characteristic (ROC) curve optimal 
cutoff value (P = .001, P = .018, P = .032, P = .008, and P 
= .001, respectively), with poorer prognosis for ROC opti-
mal values (a) less than 7.89 for entropy, (b) at least 0.01 
for uniformity, (c) less than 2.48 for kurtosis, (d) at least 
20.38 for skewness, and (e) less than 61.83 for standard 
deviation. Multivariate Cox proportional hazards regression 
analysis showed that each parameter was independent from 
the stage predictor of overall survival rate (P = .001, P = 
.009, P = .006, P = .02, and P = .001, respectively).
Conclusion: Fine-texture features are associated with poorer 5-year over-
all survival rate in patients with primary colorectal cancer.
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to September 2005 for which patients 
gave informed consent (Fig 1) (10). As 
part of their standard imaging staging, 
62 consecutive patients (30 men; mean 
age, 69.1 years; age range, 34.9–83.6 
years; 32 women; mean age, 66.8 
years; age range, 28.1–84.7 years) with 
primary colorectal cancer underwent 
standard staging contrast material–en-
hanced portal venous CT in addition 
to research perfusion CT. This clinical 
staging contrast-enhanced CT study 
was retrievable from the archive in 57 
of the 62 patients, and these patients 
comprised the study group. In each pa-
tient, localization of the tumor had been 
performed at previous colonoscopy and 
perfusion CT, and the tumor was visible 
on the staging CT image, which was of 
good quality and was without substan-
tial patient motion (Fig 1).
CT examination.— Contrast-enhanced 
CT of the chest, abdomen, and pelvis was 
performed with a four–detector row CT 
scanner (GE Lightspeed Plus; GE Health-
care, Amersham, England) by using 
the following parameters: 120 kV; 280 
mAs; 0.6-second rotation time; 5-mm 
section collimation; field of view, 300; 
matrix, 512; pixel size, 0.68 3 0.68 
mm; 75-second delay after administra-
tion of 100 mL of 340 mg/mL iodinated 
contrast material (Niopam 340; Brac-
co, Milan, Italy) at a 5 mL/sec injection 
rate with a pump injector (Percupump 
Touchscreen; E-Z-Em, Westbury, NY). 
The staging CT was reported, as per 
a well-recognized feature of malignancy 
that reflects areas of high cell density, 
necrosis, hemorrhage, and myxoid 
change (7). However, much of the het-
erogeneity visible on computed tomo-
graphic (CT) images represents photon 
noise, which can mask any underlying 
biologic heterogeneity. By using filters 
that select for image features at larger 
scales, CT texture analysis can reduce 
the effect of photon noise while en-
hancing biologic heterogeneity. Hetero-
geneity at relevant scales can be quan-
tified by using a range of parameters, 
including entropy, uniformity, kurtosis, 
skewness, and standard deviation of the 
pixel distribution histogram.
Previous studies in patients with 
colorectal cancer that have focused on 
hepatic texture have shown that higher 
hepatic entropy and lower uniformity 
(8,9) may predict poorer survival; how-
ever, to date, few studies have been 
performed to assess the texture fea-
tures of primary colorectal cancer and 
to determine if tumor texture is related 
to overall survival. The aim of this study 
was to determine if CT texture features 
of primary colorectal cancer are related 
to 5-year overall survival rate.
Materials and Methods
The University of Sussex, England, pro-
vided the software used for analysis. 
One author (B.G.) is Scientific Director 
of TexRAD (Brighton, England), and 
another (K.A.M.) is the Clinical Direc-
tor. All other authors had control of 
the data and information submitted for 
publication.
Patients
Ethical approval was obtained for this 
retrospective analysis of data acquired 
during a previously published prospec-
tive imaging research perfusion CT 
study conducted from October 2001 
Colorectal cancer is one of the commonest cancers in the West-ern world (1). Surgical resection 
of the primary tumor with curative 
intent is appropriate in approximately 
70% of patients. However, up to 30% 
of patients who undergo surgical resec-
tion of the primary tumor experience 
a subsequent relapse, usually within 
3 years, with a median time from re-
currence to death of 12 months (2–4). 
Overall prognosis is poor once recur-
rence has occurred, with liver metasta-
ses in 40%–50% of these patients (5). 
Better methods of tumor characteriza-
tion and risk stratification in patients 
for treatment at initial staging to guide 
subsequent surveillance is still needed, 
and this was highlighted as an impor-
tant area for research in an American 
Society of Clinical Oncology practice 
guideline (6).
The TNM classification is the most 
widely used staging system. In patients 
with colorectal cancer, this classifier is 
based on the depth of tumor invasion, 
lymph node involvement, and metastatic 
spread, but it does not take into account 
spatial heterogeneity. Heterogeneity is 
Implication for Patient Care
 n The addition of texture analysis 
to staging contrast-enhanced CT 
may improve prognostication in 
patients with primary colorectal 
cancer.
Advances in Knowledge
 n Kaplan-Meier survival plots for 
tumor fine-texture entropy, uni-
formity, kurtosis, skewness, and 
standard deviation of the pixel 
distribution histogram were sig-
nificantly different for tumors 
above and below each threshold 
value (receiver operating charac-
teristic [ROC] optimal cutoff 
value of P = .001, P = .018, P = 
.032, P = .008, and P = .001, re-
spectively); poorer survival was 
noted for ROC optimal cutoff 
values (7.89, .0.01, 2.48, 
.20.38, and 61.83 for entropy, 
uniformity, kurtosis, skewness, 
and standard deviation of the 
pixel distribution histogram, 
respectively).
 n Cox regression analysis with 
stage as a dependent covariate 
showed texture features were an 
independent predictor of 5-year 
overall survival rate.
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dichotomized with respect to the ROC 
optimum point. Multivariate Cox pro-
portional hazards regression analysis 
was performed to assess whether any 
of the Kaplan-Meier significant texture 
parameters were independent predic-
tors of overall survival next to the tumor 
stage. Correlations between texture 
features were assessed by using Spear-
mann rank correlation. A two-tailed P 
value of less than .05 was considered 
to indicate a significant difference. A 
power calculation was also performed. 
All statistical analysis was performed by 
a statistician (R.K.) using R software 
(version 2.14.2; R Foundation for Sta-
tistical Computing, Vienna, Austria).
Results
Patients
Follow-up data were available in 55 of 
57 patients. There were eight stage I, 
19 stage II, 17 stage III, and 11 stage IV 
cancers. Of these, 26 were in the rec-
tum, 12 were in the sigmoid colon, two 
were in the descending colon, one was 
in the transverse colon, three were in 
the ascending colon, and 11 were in the 
cecum. Twenty-six of the 55 patients 
died within 45 months of the initial CT 
distribution histogram, higher kurto-
sis, and lower skewness represent in-
creased heterogeneity.
Staging and follow-up.—The over-
all tumor stage of each patient was re-
corded as part of the original imaging 
research study and derived from path-
ologic staging (local-regional) and CT 
staging (distant). Stage grouping was 
derived from the TNM stage, as per the 
American Joint Committee on Cancer 
(11). Patients were followed up as part 
of the research study, and data were 
censored 5 years after imaging if pa-
tients were still alive.
Statistical Analysis
Texture features were compared be-
tween aggregated stage I/II and stage 
III/IV tumors based on the original 
staging information (from pathologic 
analysis and imaging) recorded as part 
of the original research study by using 
the Mann-Whitney test. Receiver oper-
ating characteristic (ROC) curve and 
Kaplan-Meier analyses were performed 
to determine the relationship, if any, be-
tween CT texture features of the tumor, 
tumor stage, and 5-year overall survival 
rate. For the purpose of analysis, each 
texture parameter at the different filter 
values (fine, medium, and coarse) was 
usual institutional clinical practice, at the 
time of acquisition.
Texture analysis.—The contrast-en-
hanced CT studies were retrieved from 
the institution archive and loaded to a 
standard workstation for further tex-
tural analysis. This was performed by 
one observer (F.N., a radiologist with 
5 years of experience with abdominal 
CT) who was blinded to clinical out-
come. The technique comprised an ini-
tial filtration step in which a Laplacian 
of Gaussian spatial band-pass filter was 
used to selectively extract features of 
different sizes and intensity variations 
(Appendix E1 [online]). This resulted 
in a series of derived images displaying 
features at different spatial scales from 
fine to coarse texture within a region 
of interest (ROI) drawn around the co-
lorectal tumor (Fig 2). The scale was 
selected by tuning the filter parameter 
between 1.0 and 2.5, where 1.0 indi-
cates fine texture (features of approxi-
mately 4 pixels or 2.72 mm in width), 
1.5 and 2.0 indicate degrees of medium 
textures (features of approximately 6 
pixels or 4.08 mm and approximately 
10 pixels or 6.8 mm in width, respec-
tively), and 2.5 indicates coarse texture 
(features of approximately 12 pixels 
or 8.16 mm in width). An ROI was 
delineated initially around the tumor 
outline for the largest cross-sectional 
area. The ROI was then propagated au-
tomatically by the software to include 
the entire tumor volume. The ROI was 
further refined by the exclusion of areas 
of air with a thresholding procedure 
that removed from analysis any pixels 
with attenuation values below 250 HU. 
Where necessary, the ROI was further 
adjusted manually at each individual 
level or section. This was performed in 
no more than 45% of sections in every 
patient. Heterogeneity within this ROI 
was quantified with and without image 
filtration, calculating entropy (irreg-
ularity) and uniformity (distribution 
of gray level), kurtosis (magnitude of 
pixel ditribution), skewness (skewness 
of pixel distribution), and standard de-
viation of the pixel distribution histo-
gram (Appendix E1 [online]). In gen-
eral, higher entropy, lower uniformity, 
higher standard deviation of the pixel 
Figure 1
Figure 1: Schematic shows recruitment pathway of patients for this study. IV = intravenous.
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Figure 2
Table 1
Entropy, Uniformity, Kurtosis, Skewness, and Standard Deviation of Pixel Distribution 
Histogram without Filtration and for Absolute Filter Scale Values Depicting Fine, 
Medium, and Coarse Textures
Filter Scale Values Entropy Uniformity Kurtosis Skewness
Standard Deviation  
of Pixel Distribution 
Histogram
No filtration 7.06 6 0.19 0.01 6 0.001 0.54 6 1.23 20.47 6 0.43 34.91 6 4.71
1.0 (fine) 7.88 6 0.22 0.01 6 0.001 1.88 6 1.57 20.34 6 0.44 60.43 6 9.75
1.5 (medium) 7.88 6 0.26 0.01 6 0.001 1.79 6 1.66 20.50 6 0.50 62.15 6 12.33
2.0 (medium) 7.88 6 0.29 0.01 6 0.001 1.49 6 1.63 20.52 6 0.55 63.06 6 13.66
2.5 (coarse) 7.83 6 0.33 0.01 6 0.001 1.29 6 1.64 20.53 6 0.57 62.14 6 15.05
Note.—Data are mean 6 standard deviation.
Figure 2: (a) Fused anatomic and texture 
contrast-enhanced CT image of a rectal tumor in a 
28-year-old woman. (b–d) Corresponding images 
in the same patient selectively display (b) fine, 
(c) medium, and (d) coarse textures and were 
obtained by using filter values of 1.0 (2.72-mm 
width, 4 pixels), 1.5 (4.08-mm width, 6 pixels), 
and 2.5 (8.16-mm width, 12 pixels). (e) Histogram 
shows pixel distribution in this patient.
examination. Median survival for pa-
tients with stage III/IV disease was 20.9 
months. The shortest survival time was 
1 month. Median survival for patients 
with stage I/II disease was not reached 
in the study period. Of the 26 patients 
who died, 17 were found to have dis-
tant metastases (nine at staging, eight 
subsequent to treatment), and one had 
a synchronous tumor.
Texture Features
There was no significant difference in 
entropy (P = .44 to P = .92), unifor-
mity (P = .39 to P = .91), kurtosis (P 
= .19 to P = .99), skewness (P = .18 to 
P = .96), or standard deviation of the 
pixel distribution histogram (P = .36 to 
P = .97) when aggregated stage I/II and 
stage III/IV tumors were compared at 
all filter levels (Table 1).
Kaplan-Meier curves were signifi-
cantly different for all parameters for fine 
texture (Fig 3, Table 2). Kaplan-Meier 
analysis also enabled us to confirm that 
tumor stage (stage I/II vs stage III/IV) 
was a predictor of overall survival (Fig 
4). The multivariate Cox PH regression 
analysis indicated that at a filter value of 
1.0, entropy, uniformity, kurtosis, skew-
ness, and standard deviation of the pixel 
distribution histogram were separately in-
dependent predictors of overall survival, 
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(r = 20.98, P < .001) and between uni-
formity and standard deviation of the 
pixel distribution histogram (r = 20.94, 
P < .001); strong positive correlation was 
noted between entropy and standard 
deviation of the pixel distribution histo-
gram (r = 0.98, P < .001), and moderate 
negative correlation was noted between 
kurtosis and skewness (r = 20.40, P = 
.003) (Table 4).
The log-rank test power, assuming 
5% significance, was between 52% for 
kurtosis and 84% and 87% for stan-
dard deviation of the pixel distribution 
histogram and entropy, respectively.
Discussion
In our study, we used whole-tumor vol-
umetric textural analysis and found that 
tumors demonstrating less heterogene-
ity at fine filter levels were associated 
with poorer survival and that tumor 
entropy less than or equal to 7.89, 
in addition to the aggregated tumor 
stage (stage I/III vs stage III/IV) (Table 
3). Strong negative correlations were 
noted between entropy and uniformity 
Figure 3
Figure 3: Kaplan-Meier curves at a filter value of 
1.0 show a significant difference in survival for (a) 
entropy, (b) uniformity, (c) kurtosis, (d) skewness, 
and (e) standard deviation of the pixel distribution 
histogram with log-rank P values of .001, .018, 
.032, .008 and .001, respectively.
Figure 4
Figure 4: Kaplan-Meier curves show a significant 
difference in survival for stage, with log rank P value 
of .001.
uniformity greater than 0.01, kurtosis 
less than or equal to 2.48, skewness 
greater than 20.38, and standard devi-
ation of the pixel distribution histogram 
less than or equal to 61.83 were associ-
ated with poorer 5-year overall survival.
Assessment of tumor heterogeneity 
is relevant to everyday clinical practice. 
It has been proposed that greater bio-
logic heterogeneity may be associated 
with oxidative stress, promotion of 
survival factors, and genomic instabil-
ity (7,12,13). To date, no studies have 
directly addressed primary colorectal 
cancer heterogeneity; however, several 
studies have suggested that increas-
ing heterogeneity is associated with 
malignancy. One study of 220 nodes 
in patients with colorectal cancer sug-
gested that CT texture features of ma-
lignant and benign nodes may differ, 
with greater heterogeneity noted in 
malignant nodes (14). In a study of 21 
patients with primary esophageal can-
cer (15), correlating unenhanced CT 
texture analysis with positron emission 
tomography standardized uptake value 
(SUV) and clinical staging, coarse tex-
ture uniformity correlated negatively 
and entropy correlated positively with 
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associated with a poorer prognosis, lead-
ing us to hypothesize that these might 
be tumors with greater cell packing and 
more uniform distribution of vasculari-
zation and contrast enhancement. Given 
that the majority of colorectal tumors 
show moderate differentiation, this tex-
ture feature may augment current char-
acterization and is promising as an ad-
ditional prognostic biomarker to tumor 
stage. This may be particularly pertinent 
heterogeneity at texture analysis. Pre-
vious histologic studies have shown, for 
example, that poor pericyte coverage of 
tumor vessels (leading to increased vas-
cular leakiness) is associated with an 
increased likelihood of nodal and dis-
tant metastases and a reduced survival 
rate (20).
In our study, we found that primary 
tumors that demonstrated greater ho-
mogeneity at a fine-texture level were 
standardized uptake value, while high-
er-stage tumors demonstrated greater 
heterogeneity at medium (3.92-mm 
pixel width in this study) but not fine 
textures (15). In a study of 17 patients 
with non–small cell lung cancer, un-
enhanced CT texture analysis coarse 
texture uniformity also correlated neg-
atively with tumor stage (16); however, 
uniformity correlated negatively with 
the standardized uptake value. Other 
studies focusing on hepatic texture in 
patients with colorectal cancer have 
found a more heterogeneous liver tex-
ture at coarse textures is related to the 
presence of occult malignancy and a 
poorer prognosis (17,18).
Our study results differ from the 
results of other published studies, for 
which there may have been several fac-
tors: First, in our study, the whole tu-
mor was assessed rather than a single 
axial level, as was the case in previous 
studies. This theoretically provides a 
more representative picture of tumor 
heterogeneity than that provided by 
single-level analysis. Second, these 
were contrast-enhanced CT images 
rather than unenhanced CT images. 
Third, this may reflect the differences 
in underlying tumor biology between 
different tumor types. Our findings and 
the findings of other studies highlight 
that there are key differences in texture 
features at different scales and between 
unenhanced and contrast-enhanced CT 
images. At a coarse scale, heterogene-
ity has been ascribed predominantly to 
the heterogeneity of the tumor vascu-
lar supply; this has been supported by 
computer simulation studies (19). At a 
fine scale, texture features may reflect 
cellular distribution on unenhanced im-
ages; however, on contrast-enhanced 
images, texture features will also reflect 
the distribution of the contrast agent 
between the intra- and extravascular 
extracellular space. A hypothesis is 
that our contrast-enhanced CT findings 
may be related to the effects of tumor 
vascular permeability. Tumors demon-
strating higher vascular permeability 
and leading to greater parenchymal en-
hancement and lower contrast resolu-
tion between parenchyma and adjacent 
vessels may actually demonstrate less 
Table 2
Summary of ROC and Kaplan-Meier Analysis for Entropy, Uniformity, Kurtosis, 
Skewness, and Standard Deviation of Pixel Distribution Histogram
Filtration and Fine-Texture Feature ROC Threshold
Median Survival (mo)
P ValueAbove Threshold Below Threshold
No filtration
 Entropy 7.06 60* (25) 45 (30) .73
 Uniformity .0.01 42 (12) 60* (43) .49
 Kurtosis .0.61 37 (19) 60* (36) .18
 Skewness .20.39 18 (14) 60* (41) .004
 Standard deviation of pixel  
 distribution histogram
36.58 60* (18) 39 (37) .13
Filter value = 1.0 (fine)
 Entropy 7.89 60* (28) 20 (27) .001
 Uniformity .0.01 32 (32) 60* (23) .018
 Kurtosis 2.48 60* (15) 40 (40) .032
 Skewness .20.38 21 (29) 60* (26) .008
 Standard deviation of pixel  
 distribution histogram
61.83 60* (26) 20 (29) .001
Filter value = 1.5 (medium)
 Entropy 7.92 60* (24) 27 (31) .01
 Uniformity .0.01 37 (13) 60* (42) .19
 Kurtosis 1.95 60* (16) 40 (39) .07
 Skewness .20.62 27 (29) 60* (26) .03
 Standard deviation of pixel  
 distribution histogram
61.42 60* (24) 27 (31) .003
Filter value = 2.0 (medium)
 Entropy 7.98 60* (18) 39 (37) .049
 Uniformity .0.01 45 (35) 60* (20) .37
 Kurtosis 0.70 60* (42) 27 (13) .09
 Skewness .20.54 27 (23) 60* (32) .15
 Standard deviation of pixel  
 distribution histogram
63.85 60* (24) 27 (31) .01
Filter value = 2.5 (coarse)
 Entropy 7.80 60* (29) 38 (26) .14
 Uniformity .0.01 39 (32) 60* (23) .15
 Kurtosis .0.99 41 (26) 60* (29) .22
 Skewness .20.48 45 (35) 60* (20) .59
 Standard deviation of pixel  
 distribution histogram
65.87 60* (17) 39 (38) .03
Note.—Data in parentheses are numbers of patients.
* Cumulative survival probability was above 0.5 at 60 months follow-up.
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poorer 5-year overall survival rate in 
patients with colorectal cancer. With 
the shift from adjuvant to neoadjuvant 
chemotherapy for colorectal cancer 
and the ease of introducing such post-
processing tools into the clinical work-
flow, texture analysis shows promise as 
a clinical prognostic tool.
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Fine-Texture Feature Entropy Uniformity Kurtosis Skewness
Standard  
Deviation of Pixel  
Distribution 
Histogram
Entropy … 20.98 (,.001) 20.09 (.537) 20.11 (.424) 0.98 (,.001)
Uniformity 20.98 (,.001) … 0.2 (.140) 0.09 (.505) 20.94 (,.001)
Kurtosis 20.09 (.537) 0.2 (.140) … 20.4 (.003) 0.05 (.744)
Skewness 20.11 (.424) 0.09 (.505) 20.4 (.003) … 20.15 (.274)
Standard deviation of  
pixel distribution 
histogram
0.98 (,.001) 20.94 (,.001) 0.05 (.744) 20.15 (.274) …
Note.—Data in parentheses are P values.
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